Search
for

    Glossary Hepatocellular Carcinoma

    most common type of primary liver cancer, often called HCC

    Hepatocellular Carcinoma (HCC) is the most common type of primary liver cancer, originating from the main type of liver cells called hepatocytes. It often develops in the context of chronic liver diseases such as cirrhosis or hepatitis B and C infections, and it can lead to symptoms like abdominal pain, weight loss, and jaundice.

    Research 10 of 921

    1. Sorafenib combined with hepatectomy in patients with intermediate-stage and advanced hepatocellular carcinoma Archives of Medical Science · 2017 · 16 citations
    2. Lichen myxedematosus in a patient with hepatocellular carcinoma British Journal of Dermatology · 2000 · 16 citations
    3. Preponderance of serum and intra-hepatic 5α-dihydrotestosterone in males with hepatocellular carcinoma despite low circulating androgen levels Journal of hepatology · 1986 · 8 citations
    4. Predicting therapeutic drugs for hepatocellular carcinoma based on tissue-specific pathways PLoS Computational Biology · 2021 · 69 citations
    5. Medical Treatment of Hepatocellular Carcinoma: Any Progress? Tumori Journal · 1994 · 19 citations
    6. Phytochemical and nanoparticle-based therapeutic potential of Sphaeranthus indicus against hepatocellular carcinoma via cryptomeridiol targeting Frontiers in Oncology · 2025
    7. Efficacy and safety of the oral Janus kinase 3/tyrosine kinase expressed in hepatocellular carcinoma family kinase inhibitor ritlecitinib over 24 months: integrated analysis of the ALLEGRO phase IIb/III and long-term phase III clinical studies in alopecia areata British Journal of Dermatology · 2024 · 23 citations
    8. Potential Consequences of the Use of Adipose-Derived Stem Cells in the Treatment of Hepatocellular Carcinoma International Journal of Molecular Sciences · 2024 · 2 citations
    9. Transarterial chemoembolization (TACE) combined with donafenib as first-line therapy for unresectable hepatocellular carcinoma (uHCC): A real-world clinical study. Journal of Clinical Oncology · 2024
    10. Author response: Deletion of the MAD2L1 spindle assembly checkpoint gene is tolerated in mouse models of acute T-cell lymphoma and hepatocellular carcinoma 2017
    All research results →

    Learn

    — no results

    Try a deeper search in learn →

    Community

    — no results

    Try a deeper search in community →